She stated this during an online meeting of the Scientific Council of the Russian Academy of Sciences.

"We have confirmed the high safety of the vaccine, we have not registered a single vaccine-associated serious side effect and not a single death that may be associated with the use of the vaccine," RIA Novosti quotes Egorova.

Egorova also said that the study of the Sputnik V vaccine on patients with cancer is planned to begin in the coming months.